BASTIDE LE CONFORT MEDICAL (BLC.PA) Stock Fundamental Analysis
EPA:BLC - Euronext Paris - Matif - FR0000035370 - Common Stock - Currency: EUR
We assign a fundamental rating of 4 out of 10 to BLC. BLC was compared to 25 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of BLC while its profitability can be described as average. BLC has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
BLC had positive earnings in the past year.
BLC had a positive operating cash flow in the past year.
BLC had positive earnings in 4 of the past 5 years.
In the past 5 years BLC always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of BLC (0.25%) is worse than 76.92% of its industry peers.
BLC's Return On Equity of 2.25% is on the low side compared to the rest of the industry. BLC is outperformed by 73.08% of its industry peers.
With a decent Return On Invested Capital value of 5.65%, BLC is doing good in the industry, outperforming 65.38% of the companies in the same industry.
BLC had an Average Return On Invested Capital over the past 3 years of 5.34%. This is in line with the industry average of 5.91%.
The 3 year average ROIC (5.34%) for BLC is below the current ROIC(5.65%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 2.25% | ||
| ROIC | 5.65% |
ROA(3y)1.29%
ROA(5y)1.7%
ROE(3y)9.6%
ROE(5y)12.13%
ROIC(3y)5.34%
ROIC(5y)5.17%
1.3 Margins
BLC's Profit Margin of 0.32% is on the low side compared to the rest of the industry. BLC is outperformed by 73.08% of its industry peers.
With a decent Operating Margin value of 7.67%, BLC is doing good in the industry, outperforming 65.38% of the companies in the same industry.
In the last couple of years the Operating Margin of BLC has grown nicely.
Looking at the Gross Margin, with a value of 67.54%, BLC is in the better half of the industry, outperforming 73.08% of the companies in the same industry.
In the last couple of years the Gross Margin of BLC has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.67% | ||
| PM (TTM) | 0.32% | ||
| GM | 67.54% |
OM growth 3Y3.59%
OM growth 5Y6.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.18%
GM growth 5Y6.9%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLC is creating some value.
The number of shares outstanding for BLC has been reduced compared to 1 year ago.
Compared to 5 years ago, BLC has more shares outstanding
The debt/assets ratio for BLC has been reduced compared to a year ago.
2.2 Solvency
BLC has an Altman-Z score of 1.40. This is a bad value and indicates that BLC is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.40, BLC is doing worse than 61.54% of the companies in the same industry.
BLC has a debt to FCF ratio of 9.33. This is a negative value and a sign of low solvency as BLC would need 9.33 years to pay back of all of its debts.
BLC has a Debt to FCF ratio (9.33) which is comparable to the rest of the industry.
A Debt/Equity ratio of 5.20 is on the high side and indicates that BLC has dependencies on debt financing.
The Debt to Equity ratio of BLC (5.20) is worse than 88.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.2 | ||
| Debt/FCF | 9.33 | ||
| Altman-Z | 1.4 |
ROIC/WACC1.18
WACC4.79%
2.3 Liquidity
A Current Ratio of 1.19 indicates that BLC should not have too much problems paying its short term obligations.
BLC has a Current ratio (1.19) which is in line with its industry peers.
BLC has a Quick Ratio of 1.19. This is a bad value and indicates that BLC is not financially healthy enough and could expect problems in meeting its short term obligations.
BLC's Quick ratio of 0.96 is in line compared to the rest of the industry. BLC outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The earnings per share for BLC have decreased strongly by -71.43% in the last year.
BLC shows a small growth in Revenue. In the last year, the Revenue has grown by 3.24%.
Measured over the past years, BLC shows a quite strong growth in Revenue. The Revenue has been growing by 9.55% on average per year.
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.77%
Revenue 1Y (TTM)3.24%
Revenue growth 3Y6.06%
Revenue growth 5Y9.55%
Sales Q2Q%3.96%
3.2 Future
BLC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.74% yearly.
Based on estimates for the next years, BLC will show a small growth in Revenue. The Revenue will grow by 5.06% on average per year.
EPS Next Y9.69%
EPS Next 2Y14.54%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue Next Year5.64%
Revenue Next 2Y5.76%
Revenue Next 3Y5.74%
Revenue Next 5Y5.06%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 125.68, which means the current valuation is very expensive for BLC.
Compared to the rest of the industry, the Price/Earnings ratio of BLC indicates a slightly more expensive valuation: BLC is more expensive than 76.92% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of BLC to the average of the S&P500 Index (26.84), we can say BLC is valued expensively.
A Price/Forward Earnings ratio of 8.09 indicates a reasonable valuation of BLC.
BLC's Price/Forward Earnings ratio is rather cheap when compared to the industry. BLC is cheaper than 92.31% of the companies in the same industry.
BLC is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.29, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 125.68 | ||
| Fwd PE | 8.09 |
4.2 Price Multiples
BLC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BLC is cheaper than 84.62% of the companies in the same industry.
BLC's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BLC is cheaper than 76.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.52 | ||
| EV/EBITDA | 5.88 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BLC does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as BLC's earnings are expected to grow with 15.74% in the coming years.
PEG (NY)12.97
PEG (5Y)N/A
EPS Next 2Y14.54%
EPS Next 3Y15.74%
5. Dividend
5.1 Amount
No dividends for BLC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:BLC (8/15/2025, 7:00:00 PM)
27.65
-0.1 (-0.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners9.28%
Inst Owner ChangeN/A
Ins Owners1.58%
Ins Owner ChangeN/A
Market Cap203.78M
Analysts83.33
Price Target33.66 (21.74%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.22
Dividend Growth(5Y)-3.5%
DP42.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 125.68 | ||
| Fwd PE | 8.09 | ||
| P/S | 0.38 | ||
| P/FCF | 4.52 | ||
| P/OCF | 1.82 | ||
| P/B | 2.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.88 |
EPS(TTM)0.22
EY0.8%
EPS(NY)3.42
Fwd EY12.36%
FCF(TTM)6.12
FCFY22.13%
OCF(TTM)15.22
OCFY55.03%
SpS73.31
BVpS10.32
TBVpS-19.15
PEG (NY)12.97
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 2.25% | ||
| ROCE | 8.61% | ||
| ROIC | 5.65% | ||
| ROICexc | 5.65% | ||
| ROICexgc | 10.3% | ||
| OM | 7.67% | ||
| PM (TTM) | 0.32% | ||
| GM | 67.54% | ||
| FCFM | 8.35% |
ROA(3y)1.29%
ROA(5y)1.7%
ROE(3y)9.6%
ROE(5y)12.13%
ROIC(3y)5.34%
ROIC(5y)5.17%
ROICexc(3y)5.7%
ROICexc(5y)5.58%
ROICexgc(3y)12.68%
ROICexgc(5y)11.8%
ROCE(3y)8.16%
ROCE(5y)7.93%
ROICexcg growth 3Y11.16%
ROICexcg growth 5Y1.85%
ROICexc growth 3Y8.09%
ROICexc growth 5Y5.81%
OM growth 3Y3.59%
OM growth 5Y6.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.18%
GM growth 5Y6.9%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.2 | ||
| Debt/FCF | 9.33 | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 103.59% | ||
| Cap/Sales | 12.41% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 105.61% | ||
| Profit Quality | 2640.05% | ||
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 1.4 |
F-Score6
WACC4.79%
ROIC/WACC1.18
Cap/Depr(3y)89.47%
Cap/Depr(5y)88.81%
Cap/Sales(3y)10.8%
Cap/Sales(5y)10.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.77%
EPS Next Y9.69%
EPS Next 2Y14.54%
EPS Next 3Y15.74%
EPS Next 5YN/A
Revenue 1Y (TTM)3.24%
Revenue growth 3Y6.06%
Revenue growth 5Y9.55%
Sales Q2Q%3.96%
Revenue Next Year5.64%
Revenue Next 2Y5.76%
Revenue Next 3Y5.74%
Revenue Next 5Y5.06%
EBIT growth 1Y3.82%
EBIT growth 3Y9.86%
EBIT growth 5Y16.32%
EBIT Next Year166.67%
EBIT Next 3Y44.23%
EBIT Next 5YN/A
FCF growth 1Y197.72%
FCF growth 3Y10.22%
FCF growth 5Y6.95%
OCF growth 1Y63.86%
OCF growth 3Y7.62%
OCF growth 5Y8.72%